Literature DB >> 11123678

Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.

K A Fields1, T Hackstadt.   

Abstract

The medically significant, obligate intracellular pathogen Chlamydia trachomatis replicates within vacuoles termed inclusions. A developmental cycle is initiated after entry into a host cell and is manifested by the transformation of infectious elementary bodies (EBs) to larger, non-infectious reticulate bodies (RBs). Analysis of the C. trachomatis genome has revealed that chlamydiae possess genes that may encode a type III secretion apparatus. In other Gram-negative pathogens, the type III secretion mechanism is used to target virulence factors directly to the host cell cytoplasm and is essential for full virulence. To evaluate the possibility of a functional type III secretion mechanism in C. trachomatis, we initially focused on a locus containing genes encoding products with similarity to chaperones (Scc1), secretion pore components (Cds1 and Cds2) and secreted proteins (CopN) from other type III systems. Gene expression was tested by reverse transcriptase-polymerase chain reaction (RT-PCR) of total RNA extracted from infected HeLa cell monolayers at 2, 6, 12 and 20 h after infection and normalized for the number of C. trachomatis genomes present. Message was detected for Scc1 at all times, whereas message for all other tested genes was detected in significant amounts at 12 h and 20 h. Immunoblot analysis with Scc1- and CopN-specific antibodies revealed that CopN and Scc1 were present in EBs, RBs and whole-culture extracts harvested 20 h after infection. CopN is homologous to the secreted protein YopN of Yersinia sp., and analysis of monolayers 20 h after infection via indirect immunofluorescence showed specific labelling of inclusion membranes when probed with CopN-specific antibodies but not with Scc1-specific antibodies. His-tagged CopN and a chlamydial cytoplasmic control protein (NrdB) were expressed in Yersinia enterocolitica containing or lacking the virulence plasmid pYV. CopN, but not NrdB, was secreted by Y. enterocolitica in a Ca2+- and pYV-dependent fashion. These data indicate that components of the putative type III apparatus of C. trachomatis are expressed and that at least one of these products is secreted by chlamydiae to the inclusion membrane. The observation that CopN is also secreted by the Yersinia type III apparatus provides support for the notion that chlamydiae secrete proteins via a type III mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123678     DOI: 10.1046/j.1365-2958.2000.02212.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  81 in total

1.  Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis.

Authors:  K Rajalingam; H Al-Younes; A Müller; T F Meyer; A J Szczepek; T Rudel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Genomic approach for analysis of surface proteins in Chlamydia pneumoniae.

Authors:  Silvia Montigiani; Fabiana Falugi; Maria Scarselli; Oretta Finco; Roberto Petracca; Giuliano Galli; Massimo Mariani; Roberto Manetti; Mauro Agnusdei; Roberto Cevenini; Manuela Donati; Renzo Nogarotto; Nathalie Norais; Ignazio Garaguso; Sandra Nuti; Giulietta Saletti; Domenico Rosa; Giulio Ratti; Guido Grandi
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Temporal expression of type III secretion genes of Chlamydia pneumoniae.

Authors:  Anatoly Slepenkin; Vladimir Motin; Luis M de la Maza; Ellena M Peterson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae.

Authors:  R Lugert; M Kuhns; T Polch; U Gross
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 3.402

5.  Expression of a functional secreted YopN-TyeA hybrid protein in Yersinia pestis is the result of a +1 translational frameshift event.

Authors:  Franco Ferracci; James B Day; Heather J Ezelle; Gregory V Plano
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

6.  Promoters for Chlamydia type III secretion genes show a differential response to DNA supercoiling that correlates with temporal expression pattern.

Authors:  Elizabeth Di Russo Case; Ellena M Peterson; Ming Tan
Journal:  J Bacteriol       Date:  2010-03-16       Impact factor: 3.490

7.  Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.

Authors:  Sandra Muschiol; Gaelle Boncompain; François Vromman; Pierre Dehoux; Staffan Normark; Birgitta Henriques-Normark; Agathe Subtil
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

8.  Structural analysis of SepL, an enteropathogenic Escherichia coli type III secretion-system gatekeeper protein.

Authors:  Brianne J Burkinshaw; Sergio A Souza; Natalie C J Strynadka
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-09-23       Impact factor: 1.056

9.  Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates.

Authors:  Kenneth A Fields; Elizabeth R Fischer; David J Mead; Ted Hackstadt
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

10.  A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Authors:  Sandra Muschiol; Leslie Bailey; Asa Gylfe; Charlotta Sundin; Kjell Hultenby; Sven Bergström; Mikael Elofsson; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.